Industry Research Reports

Home > Reports > Pharma & Healthcare > Pet Meds and Supplements - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Pet Meds and Supplements - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-11

Pages: 159 Pages

Report ld: 2636593

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Pet Meds and Supplements was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 45%.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Pet Meds and Supplements, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pet Meds and Supplements by region & country, by Type, and by Application.

The Pet Meds and Supplements market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Meds and Supplements.

Market Segmentation

Report Metric
Details
Report Title
Pet Meds and Supplements - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Pet Meds and Supplements Companies Covered
Boehringer Ingelheim, Ceva Sante Animale, Bimeda Animal Health, Dechra Pharmaceuticals, Zoetis, Merck, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical, Taconic Biosciences, Dechra Veterinary Products, Ouro Fino Saude, Norbrook, Frontline, Zesty Paws
Global Pet Meds and Supplements Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pet Meds and Supplements Market, Segment by Type
External Use

Oral Use
Global Pet Meds and Supplements Market, Segment by Application
Dogs

Cats

Rabbit

Bird

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pet Meds and Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pet Meds and Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pet Meds and Supplements in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Pet Meds and Supplements Product Introduction
    1.2 Global Pet Meds and Supplements Market Size Forecast
        1.2.1 Global Pet Meds and Supplements Sales Value (2019-2030)
        1.2.2 Global Pet Meds and Supplements Sales Volume (2019-2030)
        1.2.3 Global Pet Meds and Supplements Sales Price (2019-2030)
    1.3 Pet Meds and Supplements Market Trends & Drivers
        1.3.1 Pet Meds and Supplements Industry Trends
        1.3.2 Pet Meds and Supplements Market Drivers & Opportunity
        1.3.3 Pet Meds and Supplements Market Challenges
        1.3.4 Pet Meds and Supplements Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Pet Meds and Supplements Players Revenue Ranking (2023)
    2.2 Global Pet Meds and Supplements Revenue by Company (2019-2024)
    2.3 Global Pet Meds and Supplements Players Sales Volume Ranking (2023)
    2.4 Global Pet Meds and Supplements Sales Volume by Company Players (2019-2024)
    2.5 Global Pet Meds and Supplements Average Price by Company (2019-2024)
    2.6 Key Manufacturers Pet Meds and Supplements Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Pet Meds and Supplements Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Pet Meds and Supplements
    2.9 Pet Meds and Supplements Market Competitive Analysis
        2.9.1 Pet Meds and Supplements Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Pet Meds and Supplements Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Meds and Supplements as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 External Use
        3.1.2 Oral Use
    3.2 Global Pet Meds and Supplements Sales Value by Type
        3.2.1 Global Pet Meds and Supplements Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Pet Meds and Supplements Sales Value, by Type (2019-2030)
        3.2.3 Global Pet Meds and Supplements Sales Value, by Type (%) (2019-2030)
    3.3 Global Pet Meds and Supplements Sales Volume by Type
        3.3.1 Global Pet Meds and Supplements Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Pet Meds and Supplements Sales Volume, by Type (2019-2030)
        3.3.3 Global Pet Meds and Supplements Sales Volume, by Type (%) (2019-2030)
    3.4 Global Pet Meds and Supplements Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Dogs
        4.1.2 Cats
        4.1.3 Rabbit
        4.1.4 Bird
        4.1.5 Others
    4.2 Global Pet Meds and Supplements Sales Value by Application
        4.2.1 Global Pet Meds and Supplements Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Pet Meds and Supplements Sales Value, by Application (2019-2030)
        4.2.3 Global Pet Meds and Supplements Sales Value, by Application (%) (2019-2030)
    4.3 Global Pet Meds and Supplements Sales Volume by Application
        4.3.1 Global Pet Meds and Supplements Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Pet Meds and Supplements Sales Volume, by Application (2019-2030)
        4.3.3 Global Pet Meds and Supplements Sales Volume, by Application (%) (2019-2030)
    4.4 Global Pet Meds and Supplements Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Pet Meds and Supplements Sales Value by Region
        5.1.1 Global Pet Meds and Supplements Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Pet Meds and Supplements Sales Value by Region (2019-2024)
        5.1.3 Global Pet Meds and Supplements Sales Value by Region (2025-2030)
        5.1.4 Global Pet Meds and Supplements Sales Value by Region (%), (2019-2030)
    5.2 Global Pet Meds and Supplements Sales Volume by Region
        5.2.1 Global Pet Meds and Supplements Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Pet Meds and Supplements Sales Volume by Region (2019-2024)
        5.2.3 Global Pet Meds and Supplements Sales Volume by Region (2025-2030)
        5.2.4 Global Pet Meds and Supplements Sales Volume by Region (%), (2019-2030)
    5.3 Global Pet Meds and Supplements Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Pet Meds and Supplements Sales Value, 2019-2030
        5.4.2 North America Pet Meds and Supplements Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Pet Meds and Supplements Sales Value, 2019-2030
        5.5.2 Europe Pet Meds and Supplements Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Pet Meds and Supplements Sales Value, 2019-2030
        5.6.2 Asia Pacific Pet Meds and Supplements Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Pet Meds and Supplements Sales Value, 2019-2030
        5.7.2 South America Pet Meds and Supplements Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Pet Meds and Supplements Sales Value, 2019-2030
        5.8.2 Middle East & Africa Pet Meds and Supplements Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Pet Meds and Supplements Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Pet Meds and Supplements Sales Value
        6.2.1 Key Countries/Regions Pet Meds and Supplements Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Pet Meds and Supplements Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Pet Meds and Supplements Sales Value, 2019-2030
        6.3.2 United States Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Pet Meds and Supplements Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Pet Meds and Supplements Sales Value, 2019-2030
        6.4.2 Europe Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Pet Meds and Supplements Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Pet Meds and Supplements Sales Value, 2019-2030
        6.5.2 China Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Pet Meds and Supplements Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Pet Meds and Supplements Sales Value, 2019-2030
        6.6.2 Japan Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Pet Meds and Supplements Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Pet Meds and Supplements Sales Value, 2019-2030
        6.7.2 South Korea Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Pet Meds and Supplements Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Pet Meds and Supplements Sales Value, 2019-2030
        6.8.2 Southeast Asia Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Pet Meds and Supplements Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Pet Meds and Supplements Sales Value, 2019-2030
        6.9.2 India Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Pet Meds and Supplements Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Boehringer Ingelheim
        7.1.1 Boehringer Ingelheim Company Information
        7.1.2 Boehringer Ingelheim Introduction and Business Overview
        7.1.3 Boehringer Ingelheim Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Boehringer Ingelheim Pet Meds and Supplements Product Offerings
        7.1.5 Boehringer Ingelheim Recent Development
    7.2 Ceva Sante Animale
        7.2.1 Ceva Sante Animale Company Information
        7.2.2 Ceva Sante Animale Introduction and Business Overview
        7.2.3 Ceva Sante Animale Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Ceva Sante Animale Pet Meds and Supplements Product Offerings
        7.2.5 Ceva Sante Animale Recent Development
    7.3 Bimeda Animal Health
        7.3.1 Bimeda Animal Health Company Information
        7.3.2 Bimeda Animal Health Introduction and Business Overview
        7.3.3 Bimeda Animal Health Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Bimeda Animal Health Pet Meds and Supplements Product Offerings
        7.3.5 Bimeda Animal Health Recent Development
    7.4 Dechra Pharmaceuticals
        7.4.1 Dechra Pharmaceuticals Company Information
        7.4.2 Dechra Pharmaceuticals Introduction and Business Overview
        7.4.3 Dechra Pharmaceuticals Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Dechra Pharmaceuticals Pet Meds and Supplements Product Offerings
        7.4.5 Dechra Pharmaceuticals Recent Development
    7.5 Zoetis
        7.5.1 Zoetis Company Information
        7.5.2 Zoetis Introduction and Business Overview
        7.5.3 Zoetis Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Zoetis Pet Meds and Supplements Product Offerings
        7.5.5 Zoetis Recent Development
    7.6 Merck
        7.6.1 Merck Company Information
        7.6.2 Merck Introduction and Business Overview
        7.6.3 Merck Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Merck Pet Meds and Supplements Product Offerings
        7.6.5 Merck Recent Development
    7.7 Elanco
        7.7.1 Elanco Company Information
        7.7.2 Elanco Introduction and Business Overview
        7.7.3 Elanco Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Elanco Pet Meds and Supplements Product Offerings
        7.7.5 Elanco Recent Development
    7.8 Bayer
        7.8.1 Bayer Company Information
        7.8.2 Bayer Introduction and Business Overview
        7.8.3 Bayer Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Bayer Pet Meds and Supplements Product Offerings
        7.8.5 Bayer Recent Development
    7.9 Boehringer
        7.9.1 Boehringer Company Information
        7.9.2 Boehringer Introduction and Business Overview
        7.9.3 Boehringer Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Boehringer Pet Meds and Supplements Product Offerings
        7.9.5 Boehringer Recent Development
    7.10 Novartis
        7.10.1 Novartis Company Information
        7.10.2 Novartis Introduction and Business Overview
        7.10.3 Novartis Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Novartis Pet Meds and Supplements Product Offerings
        7.10.5 Novartis Recent Development
    7.11 Virbac
        7.11.1 Virbac Company Information
        7.11.2 Virbac Introduction and Business Overview
        7.11.3 Virbac Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Virbac Pet Meds and Supplements Product Offerings
        7.11.5 Virbac Recent Development
    7.12 Ceva
        7.12.1 Ceva Company Information
        7.12.2 Ceva Introduction and Business Overview
        7.12.3 Ceva Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Ceva Pet Meds and Supplements Product Offerings
        7.12.5 Ceva Recent Development
    7.13 Vetoquinol
        7.13.1 Vetoquinol Company Information
        7.13.2 Vetoquinol Introduction and Business Overview
        7.13.3 Vetoquinol Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Vetoquinol Pet Meds and Supplements Product Offerings
        7.13.5 Vetoquinol Recent Development
    7.14 Nexvet
        7.14.1 Nexvet Company Information
        7.14.2 Nexvet Introduction and Business Overview
        7.14.3 Nexvet Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Nexvet Pet Meds and Supplements Product Offerings
        7.14.5 Nexvet Recent Development
    7.15 Aratana Therapeutics
        7.15.1 Aratana Therapeutics Company Information
        7.15.2 Aratana Therapeutics Introduction and Business Overview
        7.15.3 Aratana Therapeutics Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Aratana Therapeutics Pet Meds and Supplements Product Offerings
        7.15.5 Aratana Therapeutics Recent Development
    7.16 Kindred Biosciences
        7.16.1 Kindred Biosciences Company Information
        7.16.2 Kindred Biosciences Introduction and Business Overview
        7.16.3 Kindred Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.16.4 Kindred Biosciences Pet Meds and Supplements Product Offerings
        7.16.5 Kindred Biosciences Recent Development
    7.17 Ambrx
        7.17.1 Ambrx Company Information
        7.17.2 Ambrx Introduction and Business Overview
        7.17.3 Ambrx Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.17.4 Ambrx Pet Meds and Supplements Product Offerings
        7.17.5 Ambrx Recent Development
    7.18 Entest Biomedical
        7.18.1 Entest Biomedical Company Information
        7.18.2 Entest Biomedical Introduction and Business Overview
        7.18.3 Entest Biomedical Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.18.4 Entest Biomedical Pet Meds and Supplements Product Offerings
        7.18.5 Entest Biomedical Recent Development
    7.19 Taconic Biosciences
        7.19.1 Taconic Biosciences Company Information
        7.19.2 Taconic Biosciences Introduction and Business Overview
        7.19.3 Taconic Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.19.4 Taconic Biosciences Pet Meds and Supplements Product Offerings
        7.19.5 Taconic Biosciences Recent Development
    7.20 Dechra Veterinary Products
        7.20.1 Dechra Veterinary Products Company Information
        7.20.2 Dechra Veterinary Products Introduction and Business Overview
        7.20.3 Dechra Veterinary Products Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.20.4 Dechra Veterinary Products Pet Meds and Supplements Product Offerings
        7.20.5 Dechra Veterinary Products Recent Development
    7.21 Ouro Fino Saude
        7.21.1 Ouro Fino Saude Company Information
        7.21.2 Ouro Fino Saude Introduction and Business Overview
        7.21.3 Ouro Fino Saude Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.21.4 Ouro Fino Saude Pet Meds and Supplements Product Offerings
        7.21.5 Ouro Fino Saude Recent Development
    7.22 Norbrook
        7.22.1 Norbrook Company Information
        7.22.2 Norbrook Introduction and Business Overview
        7.22.3 Norbrook Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.22.4 Norbrook Pet Meds and Supplements Product Offerings
        7.22.5 Norbrook Recent Development
    7.23 Frontline
        7.23.1 Frontline Company Information
        7.23.2 Frontline Introduction and Business Overview
        7.23.3 Frontline Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.23.4 Frontline Pet Meds and Supplements Product Offerings
        7.23.5 Frontline Recent Development
    7.24 Zesty Paws
        7.24.1 Zesty Paws Company Information
        7.24.2 Zesty Paws Introduction and Business Overview
        7.24.3 Zesty Paws Pet Meds and Supplements Sales, Revenue and Gross Margin (2019-2024)
        7.24.4 Zesty Paws Pet Meds and Supplements Product Offerings
        7.24.5 Zesty Paws Recent Development

 8 Industry Chain Analysis
    8.1 Pet Meds and Supplements Industrial Chain
    8.2 Pet Meds and Supplements Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Pet Meds and Supplements Sales Model
        8.5.2 Sales Channel
        8.5.3 Pet Meds and Supplements Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Pet Meds and Supplements Market Trends
    Table 2. Pet Meds and Supplements Market Drivers & Opportunity
    Table 3. Pet Meds and Supplements Market Challenges
    Table 4. Pet Meds and Supplements Market Restraints
    Table 5. Global Pet Meds and Supplements Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Pet Meds and Supplements Revenue Market Share by Company (2019-2024)
    Table 7. Global Pet Meds and Supplements Sales Volume by Company (2019-2024) & (Units)
    Table 8. Global Pet Meds and Supplements Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Pet Meds and Supplements Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Pet Meds and Supplements Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Pet Meds and Supplements Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Pet Meds and Supplements
    Table 13. Global Pet Meds and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Meds and Supplements as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Pet Meds and Supplements Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Pet Meds and Supplements Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Pet Meds and Supplements Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Pet Meds and Supplements Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Pet Meds and Supplements Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Pet Meds and Supplements Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)
    Table 22. Global Pet Meds and Supplements Sales Volume by Type (2019-2024) & (Units)
    Table 23. Global Pet Meds and Supplements Sales Volume by Type (2025-2030) & (Units)
    Table 24. Global Pet Meds and Supplements Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Pet Meds and Supplements Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Pet Meds and Supplements Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Pet Meds and Supplements Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Pet Meds and Supplements Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Pet Meds and Supplements Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Pet Meds and Supplements Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Pet Meds and Supplements Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Pet Meds and Supplements Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Pet Meds and Supplements Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)
    Table 34. Global Pet Meds and Supplements Sales Volume by Application (2019-2024) & (Units)
    Table 35. Global Pet Meds and Supplements Sales Volume by Application (2025-2030) & (Units)
    Table 36. Global Pet Meds and Supplements Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Pet Meds and Supplements Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Pet Meds and Supplements Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Pet Meds and Supplements Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Pet Meds and Supplements Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Pet Meds and Supplements Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Pet Meds and Supplements Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Pet Meds and Supplements Sales Value by Region (2019-2024) & (%)
    Table 44. Global Pet Meds and Supplements Sales Value by Region (2025-2030) & (%)
    Table 45. Global Pet Meds and Supplements Sales Volume by Region (Units): 2019 VS 2023 VS 2030
    Table 46. Global Pet Meds and Supplements Sales Volume by Region (2019-2024) & (Units)
    Table 47. Global Pet Meds and Supplements Sales Volume by Region (2025-2030) & (Units)
    Table 48. Global Pet Meds and Supplements Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Pet Meds and Supplements Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Pet Meds and Supplements Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Pet Meds and Supplements Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Pet Meds and Supplements Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Pet Meds and Supplements Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Pet Meds and Supplements Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Pet Meds and Supplements Sales Volume, (2019-2024) & (Units)
    Table 56. Key Countries/Regions Pet Meds and Supplements Sales Volume, (2025-2030) & (Units)
    Table 57. Boehringer Ingelheim Company Information
    Table 58. Boehringer Ingelheim Introduction and Business Overview
    Table 59. Boehringer Ingelheim Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Boehringer Ingelheim Pet Meds and Supplements Product Offerings
    Table 61. Boehringer Ingelheim Recent Development
    Table 62. Ceva Sante Animale Company Information
    Table 63. Ceva Sante Animale Introduction and Business Overview
    Table 64. Ceva Sante Animale Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Ceva Sante Animale Pet Meds and Supplements Product Offerings
    Table 66. Ceva Sante Animale Recent Development
    Table 67. Bimeda Animal Health Company Information
    Table 68. Bimeda Animal Health Introduction and Business Overview
    Table 69. Bimeda Animal Health Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Bimeda Animal Health Pet Meds and Supplements Product Offerings
    Table 71. Bimeda Animal Health Recent Development
    Table 72. Dechra Pharmaceuticals Company Information
    Table 73. Dechra Pharmaceuticals Introduction and Business Overview
    Table 74. Dechra Pharmaceuticals Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Dechra Pharmaceuticals Pet Meds and Supplements Product Offerings
    Table 76. Dechra Pharmaceuticals Recent Development
    Table 77. Zoetis Company Information
    Table 78. Zoetis Introduction and Business Overview
    Table 79. Zoetis Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Zoetis Pet Meds and Supplements Product Offerings
    Table 81. Zoetis Recent Development
    Table 82. Merck Company Information
    Table 83. Merck Introduction and Business Overview
    Table 84. Merck Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Merck Pet Meds and Supplements Product Offerings
    Table 86. Merck Recent Development
    Table 87. Elanco Company Information
    Table 88. Elanco Introduction and Business Overview
    Table 89. Elanco Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Elanco Pet Meds and Supplements Product Offerings
    Table 91. Elanco Recent Development
    Table 92. Bayer Company Information
    Table 93. Bayer Introduction and Business Overview
    Table 94. Bayer Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Bayer Pet Meds and Supplements Product Offerings
    Table 96. Bayer Recent Development
    Table 97. Boehringer Company Information
    Table 98. Boehringer Introduction and Business Overview
    Table 99. Boehringer Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Boehringer Pet Meds and Supplements Product Offerings
    Table 101. Boehringer Recent Development
    Table 102. Novartis Company Information
    Table 103. Novartis Introduction and Business Overview
    Table 104. Novartis Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Novartis Pet Meds and Supplements Product Offerings
    Table 106. Novartis Recent Development
    Table 107. Virbac Company Information
    Table 108. Virbac Introduction and Business Overview
    Table 109. Virbac Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Virbac Pet Meds and Supplements Product Offerings
    Table 111. Virbac Recent Development
    Table 112. Ceva Company Information
    Table 113. Ceva Introduction and Business Overview
    Table 114. Ceva Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Ceva Pet Meds and Supplements Product Offerings
    Table 116. Ceva Recent Development
    Table 117. Vetoquinol Company Information
    Table 118. Vetoquinol Introduction and Business Overview
    Table 119. Vetoquinol Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Vetoquinol Pet Meds and Supplements Product Offerings
    Table 121. Vetoquinol Recent Development
    Table 122. Nexvet Company Information
    Table 123. Nexvet Introduction and Business Overview
    Table 124. Nexvet Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Nexvet Pet Meds and Supplements Product Offerings
    Table 126. Nexvet Recent Development
    Table 127. Aratana Therapeutics Company Information
    Table 128. Aratana Therapeutics Introduction and Business Overview
    Table 129. Aratana Therapeutics Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Aratana Therapeutics Pet Meds and Supplements Product Offerings
    Table 131. Aratana Therapeutics Recent Development
    Table 132. Kindred Biosciences Company Information
    Table 133. Kindred Biosciences Introduction and Business Overview
    Table 134. Kindred Biosciences Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Kindred Biosciences Pet Meds and Supplements Product Offerings
    Table 136. Kindred Biosciences Recent Development
    Table 137. Ambrx Company Information
    Table 138. Ambrx Introduction and Business Overview
    Table 139. Ambrx Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Ambrx Pet Meds and Supplements Product Offerings
    Table 141. Ambrx Recent Development
    Table 142. Entest Biomedical Company Information
    Table 143. Entest Biomedical Introduction and Business Overview
    Table 144. Entest Biomedical Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Entest Biomedical Pet Meds and Supplements Product Offerings
    Table 146. Entest Biomedical Recent Development
    Table 147. Taconic Biosciences Company Information
    Table 148. Taconic Biosciences Introduction and Business Overview
    Table 149. Taconic Biosciences Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Taconic Biosciences Pet Meds and Supplements Product Offerings
    Table 151. Taconic Biosciences Recent Development
    Table 152. Dechra Veterinary Products Company Information
    Table 153. Dechra Veterinary Products Introduction and Business Overview
    Table 154. Dechra Veterinary Products Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Dechra Veterinary Products Pet Meds and Supplements Product Offerings
    Table 156. Dechra Veterinary Products Recent Development
    Table 157. Ouro Fino Saude Company Information
    Table 158. Ouro Fino Saude Introduction and Business Overview
    Table 159. Ouro Fino Saude Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. Ouro Fino Saude Pet Meds and Supplements Product Offerings
    Table 161. Ouro Fino Saude Recent Development
    Table 162. Norbrook Company Information
    Table 163. Norbrook Introduction and Business Overview
    Table 164. Norbrook Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. Norbrook Pet Meds and Supplements Product Offerings
    Table 166. Norbrook Recent Development
    Table 167. Frontline Company Information
    Table 168. Frontline Introduction and Business Overview
    Table 169. Frontline Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. Frontline Pet Meds and Supplements Product Offerings
    Table 171. Frontline Recent Development
    Table 172. Zesty Paws Company Information
    Table 173. Zesty Paws Introduction and Business Overview
    Table 174. Zesty Paws Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 175. Zesty Paws Pet Meds and Supplements Product Offerings
    Table 176. Zesty Paws Recent Development
    Table 177. Key Raw Materials Lists
    Table 178. Raw Materials Key Suppliers Lists
    Table 179. Pet Meds and Supplements Downstream Customers
    Table 180. Pet Meds and Supplements Distributors List
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pet Meds and Supplements Product Picture
    Figure 2. Global Pet Meds and Supplements Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pet Meds and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Pet Meds and Supplements Sales Volume (2019-2030) & (Units)
    Figure 5. Global Pet Meds and Supplements Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Pet Meds and Supplements Report Years Considered
    Figure 7. Global Pet Meds and Supplements Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Pet Meds and Supplements Players Sales Volume Ranking (2023) & (Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pet Meds and Supplements Revenue in 2023
    Figure 10. Pet Meds and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. External Use Picture
    Figure 12. Oral Use Picture
    Figure 13. Global Pet Meds and Supplements Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Pet Meds and Supplements Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Pet Meds and Supplements Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)
    Figure 16. Global Pet Meds and Supplements Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Pet Meds and Supplements Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Dogs
    Figure 19. Product Picture of Cats
    Figure 20. Product Picture of Rabbit
    Figure 21. Product Picture of Bird
    Figure 22. Product Picture of Others
    Figure 23. Global Pet Meds and Supplements Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Pet Meds and Supplements Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Pet Meds and Supplements Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)
    Figure 26. Global Pet Meds and Supplements Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Pet Meds and Supplements Price by Application (2019-2030) & (US$/Unit)
    Figure 28. North America Pet Meds and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Pet Meds and Supplements Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Pet Meds and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Pet Meds and Supplements Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Pet Meds and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Pet Meds and Supplements Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Pet Meds and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Pet Meds and Supplements Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Pet Meds and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Pet Meds and Supplements Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Pet Meds and Supplements Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Pet Meds and Supplements Sales Volume (%), (2019-2030)
    Figure 40. United States Pet Meds and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Pet Meds and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Pet Meds and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Pet Meds and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Pet Meds and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Pet Meds and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Pet Meds and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Pet Meds and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Pet Meds and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Pet Meds and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Pet Meds and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Pet Meds and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Pet Meds and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Pet Meds and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Pet Meds and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 61. Pet Meds and Supplements Industrial Chain
    Figure 62. Pet Meds and Supplements Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Description

The global market for Pet Meds and Supplements was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 45%.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Pet Meds and Supplements, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pet Meds and Supplements by region & country, by Type, and by Application.

The Pet Meds and Supplements market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Meds and Supplements.

Market Segmentation